Evidence map›Paper›PMID 12359051›Full record

ArticleJapanese journal of cancer research : Gann2002

Expression of Ly-6D on the surface of normal and neoplastic mammary epithelial cells of the mouse.

Yasukatsu Tsukada, Tetsuo Sasaki, Kazuhide Hanyu, Jumpei Enami

Open access · bronzeAbstract read
In one paragraph

Article in Japanese journal of cancer research : Gann, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yasukatsu TsukadaResearch Laboratory, Zenyaku Kogyo Co, Ltd, Tokyo, Japan. Jumpei_Enami@mail.zenyaku.co.jp
Tetsuo Sasaki
Kazuhide Hanyu
Jumpei Enami
Zenyaku Kogyo (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rat were immunized with mouse mammary epithelial cells and monoclonal antibodies (MAbs) were obtained to identify antigens stably expressed on the surface of both normal and neoplastic mammary epithelial cells of the mouse. Examination of the reactivities of the MAbs by immunofluorescence staining of tissue sections showed that one of the antibodies, MAb 2A2, reacted with luminal epithelium of the mammary gland and spontaneous mammary carcinomas of SHN mice. Further examination of the tissue lysates by western blot analysis revealed that MAb 2A2 reacts with a 17-kDa antigen expressed in normal mammary epithelial cells and mammary carcinoma cells. The antigen recognized by MAb 2A2 was absent in the lysates of liver, lung, salivary gland, kidney, small intestine, ovary and uterus. After immunoaffinity purification of the MAb 2A2-recognized antigen and determination of its N-terminal amino acid sequence, we identified the antigen as Ly-6D, also known as ThB, which belongs to a family of glycosyl-phosphatidylinositol-anchored cell surface proteins. Northern blot analysis further demonstrated that Ly-6D mRNA is expressed in the mammary gland. Based on these observations we concluded that Ly-6D is stably expressed on the surface of both normal and neoplastic mammary epithelial cells of the mouse. Ly-6D will serve as a useful epithelial cell surface marker for the study of mammary gland development, as well as for breast cancer research.

Indexed as

AnimalsAntigens, LyBlotting, WesternEpithelial CellsFemaleFluorescent Antibody TechniqueMammary Glands, AnimalMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CMice, Inbred C57BLRatsRats, WistarRNA, MessengerAntigens, LyRNA, Messenger

Identifiers

PMID12359051
PMCPMC5927127
OpenAlexW2025153034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.